Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 223 clinical trials
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants  

Primary Objective:

<ul>
  • To assess the safety profile of each SP0202 formulation and Prevnar 13 in toddlers and infants (after each and any injection).

    • 0 views
    • 19 Feb, 2024
    • 31 locations
    Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of Age

  • To compare hemagglutination inhibition (HAI) immune response of QIV-HD to QIV-SD in participants 6 months through 35 months of age
  • To describe the HAI, seroneutralization (SN), and anti-neuraminidase (NA) immune response
  • To describe the immune response to revaccination in Season 3 (Northern Hemisphere)
  • To describe the safety profile of each …

    flu symptoms
    vaccination
    quadrivalent inactivated influenza vaccine
    influenza
    hemagglutination inhibition
    • 0 views
    • 19 Feb, 2024
    • 9 locations
    Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

  • To describe the safety profile of MenACYW conjugate vaccine and a licensed meningococcal vaccine.
    • ul>

    diabetes
    vaccination
    genetic diseases
    antibiotic therapy
    poliomyelitis
    • 0 views
    • 19 Feb, 2024
    • 29 locations
    Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

  • To describe the safety profile of MenACYW conjugate vaccine and a licensed meningococcal vaccine.
    • ul>

    diabetes
    vaccination
    genetic diseases
    antibiotic therapy
    poliomyelitis
    • 0 views
    • 19 Feb, 2024
    • 29 locations
    Asian Diabetes Outcomes Prevention Trial

    The aim of this study is to identify patients with DM at high risk of CVD using elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels (>125pg/mL), and (2) intensify therapy using renin-angiotensin system (RAS) antagonists, beta-blockers and sodium glucose co-transporter-2 inhibitors (SGLT2i) for primary prevention of cardiovascular events in this high-risk …

    diabetes
    type 1 diabetes mellitus
    stenosis
    solute carrier family 5 member 2
    coronary revascularization
    • 0 views
    • 19 Feb, 2024
    Angiography-Derived FFR And IVUS for Clinical Outcomes in Patients With Coronary Artery Disease

    Comparison of Angiography-derived Fractional FLow Reserve And IntraVascular Ultrasound-guided Intervention Strategy for Clinical OUtcomes in Patients with CoRonary Artery Disease

    angiography
    stenosis
    intravascular ultrasound
    arterial disease
    heart disease
    • 2 views
    • 19 Feb, 2024
    The PREPARE Trial: Exercise Before Surgery to Improve Recovery in Older People With Frailty

    This study evaluates whether participating in a home-based exercise program leads to lower levels of complication rates and patient-reported disability after surgery. Half of the participants will be randomized into the exercise group, while the other half will be randomized into the control group.

    • 0 views
    • 19 Feb, 2024
    First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

    Primary Objectives:

    <ul>
  • Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B
  • Dose Expansion Part B: To assess …

    multiple myeloma
    carfilzomib
    monoclonal antibodies
    measurable disease
    thalidomide
    • 0 views
    • 19 Feb, 2024
    • 8 locations
    Ipatasertib + Atezolizumab to Prevent Recurrence in TNBC

    This research study involves the following investigational drugs:

    <ul>
  • Ipatasertib
  • Atezolizumab
    • ul>

    aptt
    atezolizumab
    breast cancer
    mastectomy
    ipatasertib
    • 0 views
    • 19 Feb, 2024
    Cisplatin+Pembrolizumab+RT in Vulvar Cancer

    This research is being done to see how well the combination of a standard of care drug, investigational drug, and radiation therapy work against unresectable vulvar squamous cell carcinoma.

    This research study involves the following:

    <ul>
  • Cisplatin (standard of care drug)
  • Pembrolizumab (investigational drug)
  • Radiation Therapy (standard …

    aptt
    measurable disease
    recurrent disease
    metastatic squamous cell carcinoma
    vulvar cancer
    • 0 views
    • 19 Feb, 2024